The ongoing debate surrounding the Certificate Course in Modern Pharmacology (CCMP) in Maharashtra has once again come into the spotlight, thanks to a recent clarification issued by the National Commission for Homoeopathy (NCH). This clarification, which addresses the contentious issue of homoeopaths practising outside their traditional system, has reignited discussions and protests within the medical community.
The Bridge Course Controversy
At the heart of this controversy lies the concept of "bridge courses" in India. The idea behind these courses is to provide practitioners from various medical systems with additional training, enabling them to offer primary healthcare services, especially in underserved regions. However, this proposal has consistently faced opposition from modern medicine doctors, who argue that prescribing medications is an integral part of diagnosis and clinical training and cannot be separated from the ability to manage potential complications.
Maharashtra's CCMP: A State-Specific Approach
Maharashtra's CCMP is a unique adaptation of this concept, specifically designed for homoeopathic doctors with a BHMS degree. These practitioners are offered an additional course in modern pharmacology, which has sparked intense debate and protests this year, particularly since the state began granting registration to such practitioners with the Maharashtra Medical Council (MMC).
A Legal Battle and Its Implications
The legal challenge to Maharashtra's decision to register CCMP-qualified homoeopaths with the MMC was first brought to the Bombay High Court in 2014 by the Indian Medical Association (IMA) and members of the Maharashtra Medical Council. The Supreme Court later urged the High Court to expedite the matter, but it remains unresolved to this day. The NCH's recent clarification, issued ahead of the upcoming court hearing, is significant as it sheds light on the regulatory context surrounding the CCMP.
NCH's Clarification: A Balancing Act?
According to the NCH's 2022 professional conduct regulations, homoeopathic practitioners are generally restricted from practising any other system of medicine. However, an exception is made for those who have undergone training or a course recognised by the competent authority under a National Health Programme or a central or state government programme. The NCH's clarification aims to ensure that these provisions are understood within their proper regulatory framework. Yet, it's important to note that this clarification does not grant homoeopaths blanket permission to practise modern medicine.
The Bigger Picture: Who Can Practice Modern Medicine?
The controversy surrounding the CCMP extends beyond the question of whether a homoeopath can prescribe a particular modern drug. It delves into the fundamental issue of who can be recognized, registered, and regulated as a practitioner of modern medicine and under what legal framework. Several states in India already permit practitioners of other systems, particularly Ayurveda, to prescribe defined modern medicines in specific circumstances. However, critics argue that Maharashtra has taken a step further by linking CCMP qualification to MMC registration, thereby blurring the lines between different medical systems.
A Step Back: The Importance of Context
If we take a step back and consider the broader implications, it becomes evident that this debate is not just about the practice of medicine but also about the recognition and regulation of different medical systems. The NCH's clarification, while providing some regulatory context, has not resolved the underlying tensions between modern medicine practitioners and those from other systems. As the legal battle continues, it remains to be seen how the courts will interpret the NCH's regulations and their impact on the practice of medicine in Maharashtra and potentially across India.
